Gaucher disease type 1 can be effectively managed once a diagnosis has been made. The goal of treatment is to reduce or prevent the buildup of GL-1.
There are two treatment approaches available to help manage some of the signs and symptoms of Gaucher disease type 1: substrate reduction therapy (SRT)—an oral option, and enzyme replacement therapy (ERT)—an infusion.
Gaucher disease type 1 is a rare and progressive disease, which means it can worsen over time. Treatment can help alleviate certain symptoms and may help prevent certain long term complications.
You can use the National Gaucher Foundation’s treatment finder to find a Gaucher disease specialist.
Once you have a diagnosis of Gaucher disease, you and your doctor will determine the right treatment approach. The Sanofi Genzyme CareConnectPSS® team is here to help you learn more about Gaucher disease, treatment, and ongoing management. Visit CareConnectPSS.com, or call 1-800-745-4447 and Select Option 3, M-F, 8:00 AM to 6:00 PM EST.
Our CareConnectPSS team is here for patients and their families affected by Gaucher disease.Learn More about this offering